Kisspeptin-10 is a potent endogenous agonist for GPR54, used as a vasoconstrictor and an angiogenesis inhibitor.
CAT No: R1469
CAS No: 374675-21-5
Synonyms/Alias: Kisspeptin-10;374675-21-5;Metastin (45-54);Kisspeptin-10 (human);KP-10;Human kisspeptin 10F;Metastin 45-54;UNII-FS1N52VS3S;FS1N52VS3S;CHEMBL376756;NSC 741805;Kisspeptin-10, human;KP10;Kisspeptin 10;Kisspeptin-10?;KISS1;Human metastin 45-54;Kisspeptin-10 TFA salt;GTPL1281;GTPL1283;Kisspeptin-13 (4-13) (human) trifluoroacetate salt;SCHEMBL15930211;BDBM26349;[125I]kisspeptin-10 (human);RITKWYDZSSQNJI-INXYWQKQSA-N;EX-A5793;BDBM50045513;AKOS024457174;[125I]-KP10;[125I]KP-10;DA-74772;FK109536;Metastin (45-54) amide, human, >=95%;G13213;(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-AMINO-3-(4-HYDROXYPHENYL)PROPANAMIDO]-3-CARBAMOYLPROPANAMIDO]-3-(1H-INDOL-3-YL)PROPANAMIDO]-N-[(1S)-1-{[(1S)-1-[({[(1S)-1-{[(1S)-4-CARBAMIMIDAMIDO-1-{[(1S)-1-CARBAMOYL-2-PHENYLETHYL]CARBAMOYL}BUTYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}METHYL)CARBAMOYL]-2-PHENYLETHYL]CARBAMOYL}-2-HYDROXYETHYL]SUCCINAMIDE;(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]butanediamido]-3-(1H-indol-3-yl)propanamido]-N-[(1S)-1-{[(1S)-1-[({[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}butyl]carbamoyl}-3-methylbutyl]carbamoyl}methyl)carbamoyl]-2-phenylethyl]carbamoyl}-2-hydroxyethyl]butanediamide;Human kisspeptin 10F;L-Tyrosyl-L-asparaginyl-L-tryptophyl-L-asparaginyl-L-seryl-L-phenylalanylglycyl-L-leucyl-L-arginyl-L-phenylalan inamide;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C63H83N17O14 |
M.W/Mr. | 1302.4 |
Sequence | One Letter Code:YNWNSFGLRF Three Letter Code:H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 |
Appearance | Powder |
Length | 10 |
Long-term Storage Conditions | Water (Slightly) |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
InChI | InChI=1S/C63H83N17O14/c1-34(2)24-45(58(90)74-43(18-11-23-70-63(68)69)57(89)75-44(54(67)86)26-35-12-5-3-6-13-35)73-53(85)32-72-56(88)46(27-36-14-7-4-8-15-36)77-62(94)50(33-81)80-61(93)49(30-52(66)84)79-59(91)47(28-38-31-71-42-17-10-9-16-40(38)42)78-60(92)48(29-51(65)83)76-55(87)41(64)25-37-19-21-39(82)22-20-37/h3-10,12-17,19-22,31,34,41,43-50,71,81-82H,11,18,23-30,32-33,64H2,1-2H3,(H2,65,83)(H2,66,84)(H2,67,86)(H,72,88)(H,73,85)(H,74,90)(H,75,89)(H,76,87)(H,77,94)(H,78,92)(H,79,91)(H,80,93)(H4,68,69,70)/t41-,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1 |
InChI Key | RITKWYDZSSQNJI-INXYWQKQSA-N |
Modifications | Phosphotyrosine;Phenylalanine amide |
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.